LH · Labcorp Holdings Inc. · Webcasts, Transcripts & Audio
$367.90
-0.34 (-0.09%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$29.90B
Shares
81.20M
Volume · Nov 18
106.73K
Avg daily vol (3M)
738.33K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Labcorp Holdings Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Labcorp Holdings Inc. (LH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-10
Labcorp Holdings Inc. (LH) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-28
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript
Confident tone
PAMA reimbursement risk
Third-quarter financial performance
Biopharma laboratory services
Revenue
$3.81B
▲ 6.9% YoY Diluted EPS
$3.22
▲ 3.2% YoY Gross margin
29.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Labcorp Holdings Inc. (LH) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-09-10
Labcorp Holdings Inc. (LH) September 10, 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-30
Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript
Confident tone
Biopharma Laboratory Services (BLS)
Specialty Testing / Oncology Expansion
PAMA / Regulatory & Legislative Risk
Revenue
$3.73B
▲ 5.8% YoY Diluted EPS
$3.64
▲ 28.2% YoY Gross margin
29.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Labcorp Holdings Inc. (LH) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-05-21
Labcorp Holdings Inc. (LH) May 21, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
Confident tone
Margin expansion and Launchpad productivity
Consumer health and digital engagement
Specialty testing growth areas
Revenue
$3.54B
▲ 5.8% YoY Diluted EPS
$3.35
▲ 32.9% YoY Gross margin
28.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript
Confident tone
2025 Financial Results
Specialty/Esoteric Testing Growth
Early Development/BLS
Revenue
$3.52B*
▲ 5.6% YoY Gross margin
28.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
Confident tone
Early Development weakness and restructuring
Invitae integration
Biopharma Laboratory Services (Central Lab)
Revenue
$3.56B
▲ 8.6% YoY Diluted EPS
$3.12
▲ 56% YoY Gross margin
28.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
Confident tone
Biopharma Laboratory Services (BLS) momentum
Diagnostics Laboratories segment growth
PAMA reimbursement risk
Revenue
$3.53B
▲ 9.5% YoY Diluted EPS
$2.84
▲ 16.9% YoY Gross margin
29.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Confident tone
Biopharma Laboratory Services (BLS)
2025 financial guidance
Diagnostics Laboratories growth and margin
Revenue
$3.35B
▲ 5.3% YoY Diluted EPS
$2.52
▼ 6.3% YoY Gross margin
28.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
Confident tone
2024 financial performance
Strategic acquisitions and Invitae integration
2025 guidance and outlook
Revenue
$3.33B*
▲ 9.8% YoY Gross margin
26.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-24
Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript
Positive tone
Acquisitions and Partnerships
Diagnostics and Biopharma Growth
Book-to-Bill and Early Development
Revenue
$3.28B
▲ 7.4% YoY Diluted EPS
$2.00
▼ 5.2% YoY Gross margin
27.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Labcorp Holdings Inc. (LH) Q2 2024 Earnings Call Transcript
Confident tone
Invitae acquisition
2024 guidance and margins
LaunchPad cost initiative
Revenue
$3.22B
▲ 6.2% YoY Diluted EPS
$2.43
▲ 14.6% YoY Gross margin
28.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
Labcorp Holdings Inc. (LH) Q1 2024 Earnings Call Transcript
Confident tone
Quarterly Financial Results & Guidance
Diagnostics Margin Pressure
Early Development Biopharma Weakness
Revenue
$3.18B
▲ 4.6% YoY Diluted EPS
$2.69
▲ 12.6% YoY Gross margin
28.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
Labcorp Holdings Inc. (LH) Q4 2023 Earnings Call Transcript
Confident tone
Biopharma laboratory services
2024 financial guidance
Diagnostics base business growth
Revenue
$3.03B*
▲ 39.5% YoY Gross margin
27.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-26
Labcorp Holdings Inc. (LH) Q3 2023 Earnings Call Transcript
Revenue
$3.06B
▲ 6.6% YoY Diluted EPS
$2.11
▼ 45.9% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Labcorp Holdings Inc. (LH) Q2 2023 Earnings Call Transcript
Revenue
$3.03B
▲ 3.8% YoY Diluted EPS
$2.12
▼ 45.2% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Labcorp Holdings Inc. (LH) Q1 2023 Earnings Call Transcript
Revenue
$3.04B
▼ 22.1% YoY Diluted EPS
$2.39
▼ 54.3% YoY Gross margin
28.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Labcorp Holdings Inc. (LH) Q4 2022 Earnings Call Transcript
Revenue
$2.17B*
▲ 103% YoY Gross margin
29.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Labcorp Holdings Inc. (LH) Q3 2022 Earnings Call Transcript
Revenue
$2.87B
▼ 29.4% YoY Diluted EPS
$3.90
▼ 35.5% YoY Gross margin
30.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Labcorp Holdings Inc. (LH) Q2 2022 Earnings Call Transcript
Revenue
$2.92B
▼ 23.9% YoY Diluted EPS
$3.87
▼ 18.7% YoY Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Labcorp Holdings Inc. (LH) Q1 2022 Earnings Call Transcript
Revenue
$3.90B
▼ 6.3% YoY Diluted EPS
$5.23
▼ 33.1% YoY Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Labcorp Holdings Inc. (LH) Q4 2021 Earnings Call Transcript
Revenue
$1.07B*
▼ 76.1% YoY Gross margin
69.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Labcorp Holdings Inc. (LH) Q3 2021 Earnings Call Transcript
Revenue
$4.06B
▲ 4.3% YoY Diluted EPS
$6.05
▼ 15.6% YoY Gross margin
34.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Labcorp Holdings Inc. (LH) Q2 2021 Earnings Call Transcript
Revenue
$3.84B
▲ 38.7% YoY Diluted EPS
$4.76
▲ 100.8% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Labcorp Holdings Inc. (LH) Q1 2021 Earnings Call Transcript
Revenue
$4.16B
▲ 47.4% YoY Diluted EPS
$7.82
Gross margin
38.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Labcorp Holdings Inc. (LH) Q4 2020 Earnings Call Transcript
Revenue
$4.49B*
▲ 52% YoY Gross margin
42.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Labcorp Holdings Inc. (LH) Q3 2020 Earnings Call Transcript
Revenue
$3.90B
▲ 33% YoY Diluted EPS
$7.17
▲ 218.7% YoY Gross margin
40.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Labcorp Holdings Inc. (LH) Q2 2020 Earnings Call Transcript
Revenue
$2.77B
▼ 3.9% YoY Diluted EPS
$2.37
▲ 22.8% YoY Gross margin
27.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
Labcorp Holdings Inc. (LH) Q1 2020 Earnings Call Transcript
Revenue
$2.82B
▲ 1.2% YoY Diluted EPS
$-3.27
▼ 275.8% YoY Gross margin
25.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Labcorp Holdings Inc. (LH) Q4 2019 Earnings Call
Revenue
$2.95B
▲ 6% YoY Diluted EPS
$2.32
▲ 48.7% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–33 of 33 webcasts
Key facts
CIK
920148
CUSIP
504922105
13F (30d)
1020 filings
956 filers
Visit website
Investor relations